Porcine circovirus 3 (PCV-3) is an emerging circovirus species that has recently been reported in different countries around the world, suggesting a widespread circulation. In this study, sera samples originating from 654 pigs of different production phases and clinical/pathological conditions, submitted for diagnostic purposes between 1996 and 2017, were randomly selected. Detection of PCV-3 genome in such samples was attempted with a previously described PCR method, and the par- Although the information obtained was limited, PCV-3 did not appear to be linked to any specific pathological condition or age group.
| INTRODUCTION
A new circovirus species able to infect the domestic pig has been recently described and named Porcine circovirus 3 (PCV-3). It was initially found in 2016 in tissues of swine affected by porcine dermatitis and nephropathy syndrome (PDNS), reproductive failure, and cardiac and multisystemic inflammation (Palinski et al., 2017; Phan et al., 2016) in the USA. Subsequently, other reports from Europe (Collins, McKillen, & Allan, 2017; Faccini et al., 2017; Franzo, Legnardi, Hjulsager et al., 2018; Stadejek, Wo zniak, Miłek, & Biernacka, 2017) , Asia Ku et al., 2017; Kwon, Yoo, Park, & Lyoo, 2017; Shen et al., 2017; Zhai et al., 2017; Zheng et al., 2017) and South America (Tochetto et al., 2017) described the presence of PCV-3 genome in tissue samples or sera from pigs with different clinical presentations as well as in healthy animals.
PCV-3 has a circular genome that contains 1,999-2,000 nucleotides with two major open reading frames (ORFs) oriented in opposite directions encoding capsid (Cap) and replicase (Rep) proteins (Palinski
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This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. sequence (Franzo, Legnardi, Centelleghe et al., 2018) and double distilled water were used as positive and negative controls, respectively. To demonstrate the presence of PCV-3 DNA in studied samples, a conventional PCR assay was performed; according to a previous protocol described (Franzo, Legnardi, Hjulsager et al., 2018) , three ll of extracted DNA was added to a PCR mix and amplified using the same thermal protocol. The reaction was carried out in a final volume of 50 ll mixture containing 10 ll of 59 PCR Buffer, 2 ll of 10 lM dNTPs, 1 ll of 10 pmol forward primer 
| Sequence alignment and phylogenetic analysis
Sequence analysis was performed with Finch TV program 1.4.1 (http://www.geospiza.com), the consensus was obtained utilizing ChromasPro (CromasPro Version 1.5) and sequences were aligned with 51 PCV-3 complete genomes available at the GenBank (retrieved on November 2017) using MAFFT (Kumar, Stecher, & Tamura, 2016) .
A phylogenetic tree was conducted using the maximum-likelihood (ML) method implemented in PhyML (Guindon et al., 2010) ; the robustness of the ML tree was evaluated by bootstrap analysis with 1,000 boostrap replicates. The raw genetic distance among strains was calculating using MEGA7 software (Kumar et al., 2016) . Sequences obtained were deposited at the GenBank (references MG807066 to MG807089).
| Association between the presence of PCV-3 and production phase and clinical/pathological conditions
All studied animals were classified according to their respective production phases (lactation, from 1 to 3 weeks of age; nursery, from 4 to 9 weeks of age; fatteners, >10 weeks of age; sows and foetuses were also included). Animals were still classified according to their different clinical/pathological presentations (gastrointestinal, systemic, neurological, reproductive, respiratory and other conditions such as cutaneous, musculoskeletal or inconclusive clinical signs). A number of asymptomatic animals were included as well. Table 2 summarizes the number of pigs in each production phase as well as their clinical/pathological presentation. Specifically, as previous studies reported coinfections of PCV-3 with PCV-2 (Fu et al., 2017; Ku et al., 2017) and Porcine reproductive and respiratory syndrome virus (PRRSV) (Fu et al., 2017) , two of the most important pathogens affecting pigs worldwide, the concurrent presence PCV-2 and PRRSV was also assessed. These two latter viruses were investigated for diagnostic purposes (immunohistochemistry and/or in situ hybridization) in just some of the studied animals, attending to the demand of the submitting veterinarian.
| Statistical analyses
The statistical analyses were performed using XLSTAT 365 Microsoft
Excel 2016 Statistics Software. To test for significant differences between production phases, the corresponding clinical/pathological status and the PCV-3 PCR positivity frequencies across the 22 years tested in this study, a Fisher's exact test was performed. p values <.05 were considered to be statistically significant.
| RESULTS

| PCV-3 detection by PCR
PCV-3 PCR positivity was found in 75 of 654 (11.46%) serum samples. The first PCV-3 PCR-positive sample dated back to 1996, and (Figure 1 ), the sequences were globally scattered along the phylogenetic tree.
| Sequence alignment and phylogenetic analysis
| Association between the presence of PCV-3, production phase and clinical/pathological conditions
The detection of PCV-3 genome split by production phase and clinical/pathological conditions is summarized in Table 2 . No information about production phase and clinical/pathological condition was avail- China (59.46%) (Franzo, Legnardi, Hjulsager et al., 2018; Stadejek et al., 2017; Zheng et al., 2017) . The study design of the mentioned works was different in relation to both the studied age categories and the PCR methodologies used, implying that a direct comparison of positivity frequency is not feasible. Therefore, the prevalence of the virus in the different geographical regions cannot be accurately stated at present.
The phylogenetic analysis of obtained sequences in the present retrospective study demonstrates a close distance between them and with the PCV-3 genomes available at the GenBank. Even if the genetic variability was globally low, the Spanish strains were intermingled amongst all currently available PCV-3 sequences in the phylogenetic tree. This result would suggest that PCV-3 has not shown a differentiated independent molecular evolution in the particular areas of the world where it has been detected so far. Moreover, the low genetic variability found in PCV-3 would point to a recent emergence (and consequently, a relatively short time to evolve) or, alternatively, to a slow evolution rate as has been found for PCV-1 (Cortey & Segal es, 2011) . Further phylogenetic and evolutionary studies with higher numbers of PCV-3 sequences are needed to ascertain those hypotheses.
F I G U R E 1 Phylogenetic tree based on the partial genomes (1,001 nucleotide sequences) of PCV-3 Spanish strains and PCV-3 freely available sequences at Genbank. The phylogenetic tree was constructed using the maximum-likelihood algorithm of PhyML software with 1.000 bootstrap replicates. Spanish sequences obtained in the present study and Franzo, Legnardi, Hjulsager et al. (2018) have been coloured in red and blue, respectively. Nodes demonstrating a branch support higher than 70% have been marked with a full circle [Colour figure can be viewed at wileyonlinelibrary.com]
